Cargando…

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods

BACKGROUND AND OBJECTIVE: Several novel methods have been suggested to extend a conventional value assessment to capture a more comprehensive perspective of value from a patient perspective. The objective of this research was to demonstrate a framework for implementing a combined qualitative and qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	McQueen, R. Brett, Mendola, Nicholas D., Jakab, Ivett, Bennett, Jeffrey, Nair, Kavita V., Németh, Bertalan, Inotai, András, Kaló, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043060/ https://www.ncbi.nlm.nih.gov/pubmed/36316575 http://dx.doi.org/10.1007/s41669-022-00376-w

Ejemplares similares

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
por: Jakab, Ivett, et al.
Publicado: (2020)

Proposal for capturing patient experience through extended value frameworks of health technologies
por: Inotai, András, et al.
Publicado: (2021)

Patient and Payer Preferences for Additional Value Criteria
por: Jakab, Ivett, et al.
Publicado: (2021)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018)

Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
por: Dimitrova, Maria, et al.
Publicado: (2022)

Can cost–effectiveness principles be ignored in urgent times?
por: Kaló, Zoltán, et al.
Publicado: (2021)

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings
por: Petykó, Zsuzsanna Ida, et al.
Publicado: (2021)

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
por: Kaló, Zoltán, et al.
Publicado: (2021)

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
por: Inotai, András, et al.
Publicado: (2012)

Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
por: Zelei, Tamás, et al.
Publicado: (2021)

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer
por: Tesar, Tomas, et al.
Publicado: (2017)

Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
por: Kovács, Sándor, et al.
Publicado: (2022)

Overview on Patient Centricity in Cancer Care
por: Narbutas, Šarunas, et al.
Publicado: (2017)

Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States
por: Mendola, Nicholas D, et al.
Publicado: (2022)

A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study
por: Németh, Bertalan, et al.
Publicado: (2018)

Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints
por: Barton, Nicola J, et al.
Publicado: (2007)

Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries
por: Inotai, András, et al.
Publicado: (2020)

Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
por: McQueen, R Brett, et al.
Publicado: (2011)

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
por: Tachkov, Konstantin, et al.
Publicado: (2022)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US
por: McQueen, R Brett, et al.
Publicado: (2016)

The EEC at the end of the seventies : Western European integration in the new world economic environment /
por: Inotai, András
Publicado: (1979)

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
por: Inotai, Andras, et al.
Publicado: (2018)

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
por: Pesa, Jacqueline A, et al.
Publicado: (2012)

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
por: Jakab, Ivett, et al.
Publicado: (2023)

Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review
por: Ágh, Tamás, et al.
Publicado: (2015)

Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
por: Padula, William V., et al.
Publicado: (2019)

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment
por: McQueen, R. Brett, et al.
Publicado: (2021)

Delayed payment schemes in Central-Eastern Europe and Middle-East
por: Ádám, Ildikó, et al.
Publicado: (2022)

An organizational framework and strategic implementation for system-level change to enhance research-based practice: QUERI Series
por: Stetler, Cheryl B, et al.
Publicado: (2008)

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey
por: Nair, Kavita V, et al.
Publicado: (2011)

Fine-tuning the extent and dynamics of binding cleft opening as a potential general regulatory mechanism in parvulin-type peptidyl prolyl isomerases
por: Czajlik, András, et al.
Publicado: (2017)

Factors associated with alcohol reduction in harmful and hazardous drinkers following alcohol brief intervention in Scotland: a qualitative enquiry
por: McQueen, Jean M., et al.
Publicado: (2017)

Qualitative and Quantitative Phytochemical Analysis of Ononis Hairy Root Cultures
por: Gampe, Nóra, et al.
Publicado: (2021)

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
por: Page, Robert Lee, et al.
Publicado: (2012)

Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child
por: Visveswaran, Gautam K., et al.
Publicado: (2020)

Economic Impact of Changes in Neonatal Intensive Care Unit Ventilation Strategies with the Advent of New Noninvasive Ventilation Techniques: A Review and Proposed Assessment Framework for High Flow Therapy as a Routine Respiratory Support Paradigm
por: Pietzsch, Jan B., et al.
Publicado: (2015)

Adverse event reviews in healthcare: what matters to patients and their family? A qualitative study exploring the perspective of patients and family
por: McQueen, Jean M, et al.
Publicado: (2022)

Achieving high value care for all and the perverse incentives of 340B price agreements
por: Whittington, Melanie D., et al.
Publicado: (2018)

Momentum: how to build it, keep it or get it back
por: McQueen, Michael
Publicado: (2016)

Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography
por: Dalbeth, Nicola, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e5lmegpkcoquo3pmnmni271tha